Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Urinary Tract Infection

  Free Subscription


Articles published in Int J Antimicrob Agents

Retrieve available abstracts of 22 articles:
HTML format
Text format



Single Articles


    October 2017
  1. SOBKE A, Makarewicz O, Baier M, Bar C, et al
    Empiric treatment of lower urinary tract infections in the face of spreading multi-drug resistance: in vitro study of nitroxoline effectiveness.
    Int J Antimicrob Agents. 2017 Oct 27. pii: S0924-8579(17)30374.
    PubMed     Text format     Abstract available


    September 2017
  2. KIM SA, Altshuler J, Paris D, Fedorenko M, et al
    Cefepime versus carbapenems for the treatment of urinary tract infections caused by extended-spectrum beta-lactamase producing enterobacteriaceae.
    Int J Antimicrob Agents. 2017 Sep 21. pii: S0924-8579(17)30353.
    PubMed     Text format     Abstract available


    June 2017
  3. CHIEN JY, Yu CJ, Hsueh PR
    High incidence of fluoroquinolone resistance and effect of efflux pump inhibitors on moxifloxacin resistance among Mycobacterium tuberculosis isolates causing urinary tract infection in Taiwan.
    Int J Antimicrob Agents. 2017 Jun 28. pii: S0924-8579(17)30207.
    PubMed     Text format     Abstract available


  4. SHAH KJ, Cherabuddi K, Shultz J, Borgert S, et al
    Ampicillin for the treatment of complicated urinary tract infections caused by vancomycin resistant enterococcus spp (VRE): a single-center university hospital experience.
    Int J Antimicrob Agents. 2017 Jun 27. pii: S0924-8579(17)30218.
    PubMed     Text format     Abstract available


    May 2017
  5. BOURDELLON L, Thilly N, Fougnot S, Pulcini C, et al
    Impact of selective reporting of antibiotic susceptibility test results on the appropriateness of antibiotics chosen by french general practitioners in urinary tract infections: a randomised controlled case-vignette study.
    Int J Antimicrob Agents. 2017 May 31. pii: S0924-8579(17)30173.
    PubMed     Text format     Abstract available


  6. BOIX-PALOP L, Xercavins M, Badia C, Obradors M, et al
    Emerging extended-spectrum beta-lactamase-producing Klebsiella pneumoniae causing community-onset urinary tract infections: a case-control-control study.
    Int J Antimicrob Agents. 2017 May 24. pii: S0924-8579(17)30170.
    PubMed     Text format     Abstract available


    April 2017
  7. BI W, Li B, Song J, Hong Y, et al
    Antimicrobial susceptibility and mechanisms of fosfomycin resistance in extended-spectrum beta-lactamase-producing Escherichia coli strains from urinary tract infections in Wenzhou, China.
    Int J Antimicrob Agents. 2017 Apr 26. pii: S0924-8579(17)30135.
    PubMed     Text format     Abstract available


    November 2016
  8. GUET-REVILLET H, Tomini E, Emirian A, Join-Lambert O, et al
    Piperacillin/tazobactam as an alternative antibiotic therapy to carbapenems in the treatment of urinary tract infections due to extended-spectrum beta-lactamase-producing Enterobacteriaceae: an in silico pharmacokinetic study.
    Int J Antimicrob Agents. 2016 Nov 15. pii: S0924-8579(16)30334.
    PubMed     Text format     Abstract available


    July 2016
  9. GRAU S, Luque S, Echeverria-Esnal D, Sorli L, et al
    Urinary micafungin levels are sufficient to treat urinary tract infections caused by Candida spp.
    Int J Antimicrob Agents. 2016 Jul 5. pii: S0924-8579(16)30148.
    PubMed     Text format     Abstract available


  10. WANG LH, Liu PP, Wei DD, Liu Y, et al
    Clinical isolates of uropathogenic Escherichia coli ST131 producing NDM-7 metallo-beta-lactamase in China.
    Int J Antimicrob Agents. 2016;48:41-5.
    PubMed     Text format     Abstract available


    June 2016
  11. VAN DER MEE-MARQUET N, Diene SM, Chopin F, Goudeau A, et al
    Enigmatic occurrence of NDM-7 enzyme in the community.
    Int J Antimicrob Agents. 2016;47:505-7.
    PubMed     Text format    


    May 2016
  12. VEVE MP, Wagner JL, Kenney RM, Grunwald JL, et al
    Comparison of fosfomycin to ertapenem for outpatient or step-down therapy of extended-spectrum beta-lactamase urinary tract infections.
    Int J Antimicrob Agents. 2016 May 12. pii: S0924-8579(16)30092.
    PubMed     Text format     Abstract available


    April 2016
  13. ZMARLICKA MT, Cardwell SM, Crandon JL, Nicolau DP, et al
    Evaluation of a disease state management guideline for urinary tract infection.
    Int J Antimicrob Agents. 2016 Apr 22. pii: S0924-8579(16)30051.
    PubMed     Text format     Abstract available


  14. LOB SH, Hoban DJ, Sahm DF, Badal RE, et al
    Regional differences and trends in antimicrobial susceptibility of Acinetobacter baumannii.
    Int J Antimicrob Agents. 2016;47:317-23.
    PubMed     Text format     Abstract available


    February 2016
  15. JEAN SS, Coombs G, Ling T, Balaji V, et al
    Epidemiology and antimicrobial susceptibility profiles of pathogens causing urinary tract infections in the Asia-Pacific region: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2010-2013.
    Int J Antimicrob Agents. 2016 Feb 17. pii: S0924-8579(16)00042.
    PubMed     Text format     Abstract available


    July 2015
  16. ROGER C, Nucci B, Molinari N, Bastide S, et al
    Standard dosing of amikacin and gentamicin in critically ill patients results in variable and subtherapeutic concentrations.
    Int J Antimicrob Agents. 2015;46:21-7.
    PubMed     Text format     Abstract available


    April 2015
  17. ROGERS BA, Ingram PR, Runnegar N, Pitman MC, et al
    Sequence type 131 fimH30 and fimH41 subclones amongst Escherichia coli isolates in Australia and New Zealand.
    Int J Antimicrob Agents. 2015;45:351-8.
    PubMed     Text format     Abstract available


    December 2014
  18. SAINI H, Chhibber S, Harjai K
    Azithromycin and ciprofloxacin: A possible synergistic combination against Pseudomonas aeruginosa biofilm-associated urinary tract infections.
    Int J Antimicrob Agents. 2014 Dec 16. pii: S0924-8579(14)00365.
    PubMed     Text format     Abstract available


    November 2014
  19. ABAT C, Desboves G, Olaitan AO, Chaudet H, et al
    Increasing burden of urinary tract infections due to intrinsic colistin-resistant bacteria in hospitals in Marseille, France.
    Int J Antimicrob Agents. 2014 Nov 12. pii: S0924-8579(14)00333.
    PubMed     Text format     Abstract available


    September 2014
  20. SIDJABAT HE, Seah KY, Coleman L, Sartor A, et al
    Expansive spread of IncI1 plasmids carrying blaCMY-2 amongst Escherichia coli.
    Int J Antimicrob Agents. 2014;44:203-8.
    PubMed     Text format     Abstract available


    April 2014
  21. MUSTAFA M, Chan WM, Lee C, Harijanto E, et al
    A PROspective study on the Usage patterns of Doripenem in the Asia-Pacific region (PROUD study).
    Int J Antimicrob Agents. 2014;43:353-60.
    PubMed     Text format     Abstract available


    February 2014
  22. ROBERTS MJ, Williamson DA, Hadway P, Doi SA, et al
    Baseline prevalence of antimicrobial resistance and subsequent infection following prostate biopsy using empirical or altered prophylaxis: A bias-adjusted meta-analysis.
    Int J Antimicrob Agents. 2014 Feb 9. pii: S0924-8579(14)00022.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Urinary Tract Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: